Abstracts tagged "systemic lupus erythematosus (SLE) and vasculitis"

Abstract Number: 710 • 2017 ACR/ARHP Annual Meeting
D-Dimer As an Early Marker in Patients with Lupus Mesenteric Vasculitis
Xiaolei Ma¹, Bingzhu Hua¹, Hong Wang¹, Yun Zhu¹, Zhiyong Chen¹ and Lingyun Sun², ¹Department of Rheumatology and Immunology, the Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China, ²Department of Rheumatology and Immunology, the Affiliated Drum Tower Hospital, Nanjing University Medical School, nanjing, China
Background/Purpose: No early serum marker of accurate diagnosis of lupus mesenteric vasculitis (LMV) contributes to the treatment decision-making process. The study was undertaken to evaluate…
Abstract Number: 2441 • 2012 ACR/ARHP Annual Meeting
Readability and Suitability Assessment of Patient Education Materials in Rheumatic Diseases
Rennie L. Rhee¹, Joan Marie Von Feldt², H. Ralph Schumacher³ and Peter A. Merkel⁴, ¹Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Rheumatology, Univ of Pennsylvania/Philadelphia VAMC, Philadelphia, PA, ³Department of Medicine, University of Pennsylvania and VA Medical Center, Philadelphia, PA, ⁴University of Pennsylvania, Philadelphia, PA
Background/Purpose: Comprehension of health resources may be challenging for patients particularly those with limited health literacy. The objective of this study was to examine the…
Abstract Number: 278 • 2012 ACR/ARHP Annual Meeting
Evaluating Cardiovascular Risk Factors of Impaired Glucose Tolerance, Diabetes Mellitus, and Metabolic Syndrome in a Primarily Latino Population with Pediatric Rheumatic Diseases Associated with Vasculitis
Sara M. Stern¹, Jamie Wood², Katherine AB Marzan¹, Andreas Reiff¹, Bracha Shaham¹ and Diane Brown¹, ¹Division of Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA, ²Division of Endocrinology, Children's Hospital Los Angeles, Los Angeles, CA
Background/Purpose: Pediatric (PED) systemic rheumatic diseases associated with vasculitis (DAV) such as Systemic Lupus Erythematosus (SLE), Mixed Connective Tissue Disease (MCTD) and the various systemic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].